Abstract:Emodin--a major component of Rheum palmatum L.-exerts antiproliferative effects in cancer cells that are regulated by different signaling pathways. Hepatocellular carcinoma has high-incidence rates and is associated with poor prognosis and high mortality rates. This study was designed to evaluate the effects of emodin on human hepatocarcinoma cell viability and investigate its mechanisms of action in Huh7, Hep3B, and HepG2 cells. To define the molecular changes associated with this process, expression profiles were compared in emodin-treated hepatoma cells by cDNA microarray hybridization, quantitative RT-PCRs, and Western blot analysis. G2/M phase arrest was observed in all 3 cell lines. Cell cycle regulatory gene analysis showed increased protein levels of cyclin A, cyclin B, Chk2, Cdk2, and P27 in hepatoma cells after time courses of emodin treatment, and Western blot analysis showed decreased protein levels of Cdc25c and P21. Microarray expression profile data and quantitative PCR revealed that 15 representative genes were associated with emodin treatment response in hepatoma cell lines. The RNA expression levels of CYP1A1, CYP1B1, GDF15, SERPINE1, SOS1, RASD1, and MRAS were upregulated and those of NR1H4, PALMD, and TXNIP were downregulated in all three hepatoma cells. Moreover, at 6h after emodin treatment, the levels of GDF15, CYP1A1, CYP1B1, and CYR61 were upregulated. Here, we show that emodin treatment caused G2/M arrest in liver cancer cells and increased the expression levels of various genes both in mRNA and protein level. It is likely that these genes act as biomarkers for hepatocellular carcinoma therapy.

Design and Synthesis of Novel Anti-Proliferative Emodin Derivatives and Studies on Their Cell Cycle Arrest, Apoptosis Pathway and Migration

Synthesis, Characterization, and Anticancer Activity of Novel Lipophilic Emodin Cationic Derivatives

Antitumor Effects and Mechanism of Novel Emodin Rhamnoside Derivatives against Human Cancer Cells In Vitro

Design and Synthesis of Novel Dehydroepiandrosterone Analogues As Potent Antiproliferative Agents

Synthesis, SAR and pharmacological characterization of novel anthraquinone cation compounds as potential anticancer agents

Antitumor Effects of Emodin on LS1034 Human Colon Cancer Cells in Vitro and in Vivo: Roles of Apoptotic Cell Death and LS1034 Tumor Xenografts Model

Synthesis and biological activity evaluation of emodin quaternary ammonium salt derivatives as potential anticancer agents

Chemical Synthesis and Antitumor Activities of Emodin Derivatives

Development of Novel Erythromycin Derivatives with Inhibitory Activity Against Proliferation of Tumor Cells

Anti-Cancer Effects Of Emodin On Hepg2 Cells As Revealed By H-1 Nmr Based Metabolic Profiling

Emodin Inhibits the Growth of Hepatoma Cells: Finding the Common Anti-Cancer Pathway Using Huh7, Hep3B, and HepG2 Cells.

Apoptosis-inducing activity of new pyrazole emodin derivatives in human hepatocellular carcinoma HepG2 cells.

Design, Synthesis, and Anticancer Activity of Novel Enmein-Type Diterpenoid Derivatives Targeting the PI3K/Akt/mTOR Signaling Pathway

[Synthesis of Emodin Derivatives and Their Inhibiting Effects on Proliferation of Leukemia Cell Lines].

Design, Synthesis and Preliminary Antiproliferative Activity Studies of New Diheteroaryl Thioether Derivatives

Design, Synthesis and Biological Evaluation of a Series of New Resveratrol Analogues As Potential Anti-Cancer Agents

Anticancer potential of emodin

Emodin Promotes Apoptosis of Human Endometrial Cancer Through Regulating the MAPK and PI3K/ AKT Pathways

Design, Synthesis, and Biological Evaluation of (2E)-(2-oxo-1, 2-Dihydro-3h-indol-3-ylidene)acetate Derivatives As Anti-Proliferative Agents Through Ros-Induced Cell Apoptosis

Emodin Inhibits the Proliferation and Migration of B16F10 Cells and Induces Their Apoptosis

Synthesis and Cytotoxicity of Emodin Derivatives